Tag Archives: MSB

Hot Blue Chip Stocks To Watch For 2019

General Electric was blasted on Wednesday by workers, retirees and shareholders bemoaning the downfall of the company they love.

At its annual meeting, GE (GE) got an earful from employees and investors who pleaded with management to right the ship after a disastrous year.

“I believe it was arrogance and a series of bad business decisions,” former employee Bill Freeda said. “Our board of directors clearly has been AWOL.”

Another shareholder said: “GE, which was once one of the preeminent companies in the world — the bluest of blue chips — is now an embarrassment.”

The past 12 months has been one of the darkest periods in GE’s 126-year history. A cash crisis, brought on by years of bad deal-making, forced GE to cut its dividend in half and lay off thousands of workers. GE’s stock price has crashed by 50%, and calls to kick it out of the Dow have grown louder.

Despite the deep criticism of past and current GE leaders, the company’s nominees to the board were all elected on Wednesday. None of the shareholder proposals calling for reform were adopted, though one pushing for splitting the CEO and chairman roles received strong support.

Hot Blue Chip Stocks To Watch For 2019: Mesabi Trust(MSB)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The past year has been a good one for stocks, but only the best dividend stocks have been able to deliver gains of 50% or more while still sporting at least a 4% yield. Still, a handful of stocks have made the cut. Below, we’ll look more closely at Mesabi Trust (NYSE:MSB), Macy’s (NYSE:M), and Seagate Technology (NASDAQ:STX) to see how they accomplished this impressive feat and whether they still have further gains in store for new investors.

Hot Blue Chip Stocks To Watch For 2019: NxStage Medical, Inc.(NXTM)

Advisors’ Opinion:

  • [By Max Byerly]

    NxStage Medical (NASDAQ:NXTM) and IRIDEX (NASDAQ:IRIX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, profitability, dividends and earnings.

  • [By Dan Caplinger]

    For nine months now, investors in NxStage Medical (NASDAQ:NXTM) have looked forward to the future. Having received and accepted a bid from Fresenius Medical Care (NYSE:FMS) last August to purchase the company for $30 per share in cash, NxStage has seen a lot more volatility in its stock than most acquisition targets. With a key deadline approaching within the next three months, it’s hard not to be anxious about whether the deal will actually go through.

  • [By Max Byerly]

    NxStage Medical, Inc. (NASDAQ:NXTM) reached a new 52-week high on Monday . The stock traded as high as $29.32 and last traded at $29.20, with a volume of 8721 shares traded. The stock had previously closed at $29.15.

  • [By Dan Caplinger]

    It’s been more than a year since NxStage Medical (NASDAQ:NXTM) accepted an acquisition bid from Fresenius Medical Care (NYSE:FMS). Investors have looked forward to the $30 per share in cash that Fresenius offered, but there’ve been countless delays in the process that everyone had hoped would be over by now. Indeed, with an Aug. 7 deadline under the terms of the deal, some investors had started to get more nervous about whether the acquisition would happen at all.

  • [By Max Byerly]

    ValuEngine downgraded shares of NxStage Medical (NASDAQ:NXTM) from a buy rating to a hold rating in a research note published on Thursday morning.

    NXTM has been the topic of several other research reports. BidaskClub raised NxStage Medical from a strong sell rating to a sell rating in a research note on Saturday, March 24th. Zacks Investment Research lowered NxStage Medical from a hold rating to a strong sell rating in a research note on Tuesday, May 15th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating to the stock. The company currently has a consensus rating of Hold and an average target price of $30.50.

  • [By Stephan Byrd]

    NxStage Medical (NASDAQ:NXTM) was downgraded by equities researchers at BidaskClub from a “hold” rating to a “sell” rating in a research report issued on Friday.

Hot Blue Chip Stocks To Watch For 2019: Community Trust Bancorp, Inc.(CTBI)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Community Trust Bancorp, Inc. (NASDAQ:CTBI) reached a new 52-week high and low on Wednesday . The stock traded as low as $52.30 and last traded at $52.10, with a volume of 1141 shares trading hands. The stock had previously closed at $52.05.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Community Trust Bancorp (CTBI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Community Trust Bancorp (CTBI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Community Trust Bancorp (CTBI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Blue Chip Stocks To Watch For 2019: Truett-Hurst, Inc.(THST)

Advisors’ Opinion:

  • [By Max Byerly]

    Press coverage about Truett-Hurst (NASDAQ:THST) has trended somewhat positive this week, Accern Sentiment reports. Accern identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Truett-Hurst earned a coverage optimism score of 0.19 on Accern’s scale. Accern also gave media headlines about the company an impact score of 45.6772286424113 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Joseph Griffin]

    Media coverage about Truett-Hurst (NASDAQ:THST) has been trending somewhat positive this week, Accern Sentiment reports. The research firm ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Truett-Hurst earned a daily sentiment score of 0.00 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 44.6844029134937 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

  • [By Logan Wallace]

    Media coverage about Truett-Hurst (NASDAQ:THST) has trended somewhat positive on Tuesday, Accern Sentiment reports. The research firm identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Truett-Hurst earned a daily sentiment score of 0.19 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 45.6772286424113 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Hot Blue Chip Stocks To Watch For 2019: Duff & Phelps Utilities Income, Inc.(DNP)

Advisors’ Opinion:

  • [By Shane Hupp]

    Stratos Wealth Partners LTD. lifted its holdings in DNP Select Income Fund Inc. Common Stock (NYSE:DNP) by 108.1% during the first quarter, Holdings Channel reports. The institutional investor owned 17,485 shares of the investment management company’s stock after purchasing an additional 9,084 shares during the period. Stratos Wealth Partners LTD.’s holdings in DNP Select Income Fund Inc. Common Stock were worth $180,000 as of its most recent filing with the SEC.

Top 10 Blue Chip Stocks To Buy Right Now

&l;p&g;&l;img class=&q;dam-image shutterstock size-large wp-image-1161677530&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/1161677530/960×0.jpg?fit=scale&q; data-height=&q;639&q; data-width=&q;960&q;&g; Shutterstock

If you want to clobber the stock market &a;ndash; and double your money every two or three years &a;ndash; then buying companies with &l;i&g;accelerating&l;/i&g; dividends is the easiest and safest way to do it.

And I&a;rsquo;ve got good news for you: there are nine blue chip payers likely to raise their dividends next month. So why not &a;ldquo;front run&a;rdquo; this good news and consider these shares now?

The benefit of dividend hikes? Getting a fatter income stream is an obvious reason, but it&a;rsquo;s just the start. A rising payout acts like a lever on a company&a;rsquo;s share price, prying it higher and higher with every single dividend hike.

The pattern is plain as day in this chart of &l;b&g;NextEra Energy,&l;/b&g; a supposedly &a;ldquo;boring&a;rdquo; utility that&a;rsquo;s been quietly sending its shareholders bigger and bigger dividend checks over the past five years.

Top 10 Blue Chip Stocks To Buy Right Now: Mesabi Trust(MSB)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The past year has been a good one for stocks, but only the best dividend stocks have been able to deliver gains of 50% or more while still sporting at least a 4% yield. Still, a handful of stocks have made the cut. Below, we’ll look more closely at Mesabi Trust (NYSE:MSB), Macy’s (NYSE:M), and Seagate Technology (NASDAQ:STX) to see how they accomplished this impressive feat and whether they still have further gains in store for new investors.

Top 10 Blue Chip Stocks To Buy Right Now: Ameresco, Inc.(AMRC)

Advisors’ Opinion:

  • [By Max Byerly]

    Ameresco Inc (NYSE:AMRC) has earned an average rating of “Buy” from the six ratings firms that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have given a buy recommendation to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $13.17.

  • [By Stephan Byrd]

    Ameresco Inc (NYSE:AMRC) has been assigned a consensus rating of “Buy” from the six research firms that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price target among analysts that have covered the stock in the last year is $13.17.

  • [By Max Byerly]

    Ameresco Inc (NYSE:AMRC) has been given a consensus recommendation of “Buy” by the six ratings firms that are covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and four have given a buy recommendation to the company. The average 12-month target price among analysts that have covered the stock in the last year is $13.17.

Top 10 Blue Chip Stocks To Buy Right Now: Colliers International Group Inc. (CIGI)

Advisors’ Opinion:

  • [By Logan Wallace]

    BidaskClub lowered shares of Colliers International Gr (NASDAQ:CIGI) (TSE:CIGI) from a buy rating to a hold rating in a research report released on Wednesday morning.

  • [By Logan Wallace]

    Colliers International Group (NASDAQ: CIGI) and BBX Capital Corp Class A (NYSE:BBX) are both finance companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, valuation, dividends, profitability, risk and analyst recommendations.

  • [By Ethan Ryder]

    Shares of Colliers International Group Inc (NASDAQ:CIGI) (TSE:CIGI) have been given an average rating of “Buy” by the nine ratings firms that are presently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $79.75.

Top 10 Blue Chip Stocks To Buy Right Now: MSA Safety Incorporporated(MSA)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on MSA Safety (MSA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Schwab Charles Investment Management Inc. lifted its stake in MSA Safety Inc (NYSE:MSA) by 8.4% in the second quarter, HoldingsChannel.com reports. The fund owned 236,221 shares of the industrial products company’s stock after purchasing an additional 18,285 shares during the period. Schwab Charles Investment Management Inc.’s holdings in MSA Safety were worth $22,758,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Ethan Ryder]

    MSA Safety Inc (NYSE:MSA) shares hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $103.99 and last traded at $103.62, with a volume of 6177 shares. The stock had previously closed at $100.40.

  • [By Stephan Byrd]

    Shares of MSA Safety Inc (NYSE:MSA) have been given a consensus recommendation of “Buy” by the six brokerages that are currently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $104.00.

  • [By Max Byerly]

    News stories about MSA Safety (NYSE:MSA) have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern rates the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. MSA Safety earned a coverage optimism score of 0.12 on Accern’s scale. Accern also gave news headlines about the industrial products company an impact score of 45.5089052622113 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Top 10 Blue Chip Stocks To Buy Right Now: LaSalle Hotel Properties(LHO)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on LaSalle Hotel Properties (LHO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on LaSalle Hotel Properties (LHO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Urstadt Biddle Properties (NYSE: LHO) and LaSalle Hotel Properties (NYSE:LHO) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, risk, profitability and institutional ownership.

  • [By Ethan Ryder]

    LaSalle Hotel Properties (NYSE:LHO) was the recipient of a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 6,998,340 shares, a growth of 159.3% from the May 15th total of 2,699,413 shares. Based on an average trading volume of 5,172,852 shares, the short-interest ratio is presently 1.4 days. Currently, 6.4% of the company’s stock are sold short.

Top 10 Blue Chip Stocks To Buy Right Now: Foundation Medicine, Inc.(FMI)

Advisors’ Opinion:

  • [By Chris Lange]

    Foundation Medicine Inc. (NASDAQ: FMI) shares saw a sizable jump early on Tuesday after the company announced that Roche would be acquiring all the outstanding shares. The closing of the transaction is expected to take place in the second half of 2018.

  • [By Shane Hupp]

    Shares of Foundation Medicine Inc (NASDAQ:FMI) hit a new 52-week high and low on Tuesday . The company traded as low as $108.65 and last traded at $107.25, with a volume of 22037 shares trading hands. The stock had previously closed at $107.20.

  • [By Dan Caplinger]

    Wall Street continued to struggle on Tuesday, with major benchmarks posting larger losses than those seen in recent sessions. A new round of escalation in trade conflict between the U.S. and China was the proximate cause for concerns among investors, as the White House threatened to add tariffs on another $200 billion in Chinese goods. Despite the broader worries, some companies still had good news that sent their individual shares higher. CVS Health (NYSE:CVS), Foundation Medicine (NASDAQ:FMI), and Solid Biosciences (NASDAQ:SLDB) were among the best performers on the day. Here’s why they did so well.

  • [By Todd Campbell]

    Technology stocks are staples in growth portfolios because of their eye-popping revenue growth, but technology isn’t the only sector of the stock market that boasts fast-growing companies. For example, many healthcare stocks are growing at rates that Silicon Valley would envy. In fact, Foundation Medicine (NASDAQ:FMI), Exelixis Corp (NASDAQ:EXEL), and Teladoc (NYSE:TDOC) all reported year-over-year sales growth north of 100% in first-quarter 2018.

Top 10 Blue Chip Stocks To Buy Right Now: LinkedIn Corporation(LNKD)

Advisors’ Opinion:

  • [By ]

    Private Equity 
    This is where Yale’s earned the best returns. Private equity is ownership in companies. That dramatic 93% in annual returns for the past 20 years all came from Yale’s private equity investments. Early Investments in Google (now Alphabet) (Nasdaq: GOOG) and LinkedIn (Nasdaq: LNKD) helped create these massive returns. Private equity currently makes up about 16% of Yale’s holdings.

Top 10 Blue Chip Stocks To Buy Right Now: Dave & Buster's Entertainment, Inc.(PLAY)

Advisors’ Opinion:

  • [By Joseph Griffin]

    HEROcoin (CURRENCY:PLAY) traded 15.7% lower against the dollar during the one day period ending at 21:00 PM E.T. on September 28th. One HEROcoin token can currently be bought for approximately $0.0081 or 0.00000122 BTC on cryptocurrency exchanges including CoinBene, IDEX and Kucoin. During the last seven days, HEROcoin has traded 23.2% lower against the dollar. HEROcoin has a market capitalization of $965,784.00 and $23,345.00 worth of HEROcoin was traded on exchanges in the last day.

  • [By Stephan Byrd]

    Equities analysts expect Dave & Buster’s (NASDAQ:PLAY) to report $324.81 million in sales for the current fiscal quarter, according to Zacks. Six analysts have issued estimates for Dave & Buster’s’ earnings, with estimates ranging from $320.19 million to $332.00 million. Dave & Buster’s posted sales of $304.15 million during the same quarter last year, which suggests a positive year over year growth rate of 6.8%. The firm is scheduled to report its next quarterly earnings report on Tuesday, June 5th.

  • [By Logan Wallace]

    Dynamic Technology Lab Private Ltd acquired a new position in shares of Dave & Buster’s Entertainment Inc (NASDAQ:PLAY) in the second quarter, Holdings Channel reports. The fund acquired 45,243 shares of the restaurant operator’s stock, valued at approximately $2,154,000.

Top 10 Blue Chip Stocks To Buy Right Now: United Natural Foods, Inc.(UNFI)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Investors seemed to be in a sector-shifting mood on Friday, because various measures of stock market performance went in different directions. Some areas of the market, including small-cap stocks and big technology names, were largely lower for the day. Yet the Dow Jones Industrial Average set another all-time high, and the broadest benchmarks stayed close to unchanged. Even so, amid the cross-currents of the market, some stocks suffered substantial losses, with a particular emphasis on those that had seen impressive gains recently. GTx (NASDAQ:GTXI), Tilray (NASDAQ:TLRY), and United Natural Foods (NASDAQ:UNFI) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Motley Fool Staff]

    United Natural Foods (NASDAQ:UNFI) Q3 2018 Earnings Conference CallJun. 6, 2018 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Chris Lange]

    And United Natural Foods Inc. (NASDAQ: UNFI) fiscal second-quarter report is scheduled for Thursday. The consensus forecast is $0.85 in EPS on $2.61 billion in revenue. Shares ended the week trading at $33.53 apiece. The consensus price target is $45.07, and the 52-week range is $31.84 to $52.69.

  • [By Chris Lange]

    When United Natural Foods Inc. (NASDAQ: UNFI) reported its most recent quarterly results after the markets closed on Thursday, the company said that it had $0.76 in earnings per share (EPS) and $2.59 billion in revenue. Consensus estimates had called for $0.85 in EPS and revenue of $2.61 billion, and the fiscal fourth quarter of last year reportedly had EPS of $0.72 and $2.34 billion in revenue.

  • [By Logan Wallace]

    United Natural Foods (NASDAQ:UNFI) was upgraded by equities researchers at BidaskClub from a “sell” rating to a “hold” rating in a research note issued to investors on Wednesday.

  • [By Asit Sharma]

    Last week, United Natural Foods, Inc. (NASDAQ:UNFI) shares fell more than 14% in the trading session following the company’s June 6 release of fiscal third-quarter 2018 earnings, largely on investor concerns over gross margin. The stock has recouped only a couple of percentage points to date.

Top 10 Blue Chip Stocks To Buy Right Now: Summer Infant Inc.(SUMR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Summer Infant (SUMR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    News coverage about Summer Infant (NASDAQ:SUMR) has trended somewhat positive on Sunday, Accern reports. The research firm identifies negative and positive media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Summer Infant earned a daily sentiment score of 0.12 on Accern’s scale. Accern also gave news coverage about the company an impact score of 47.9918179751106 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

  • [By Max Byerly]

    Here are some of the news headlines that may have effected Accern’s rankings:

    Get Summer Infant alerts:

    How Financially Strong Is Summer Infant Inc (NASDAQ:SUMR)? (finance.yahoo.com) Summer Infant, Inc. (SUMR) Director Buys $10,800.00 in Stock (americanbankingnews.com) Head-To-Head Survey: Summer Infant (SUMR) vs. Smiths Group (SMGZY) (americanbankingnews.com) Summer Infant Announces Upcoming Investor Events (finance.yahoo.com) Summer Infant, Inc. (SUMR) Receives Average Rating of “Strong Buy” from Analysts (americanbankingnews.com)

    SUMR has been the topic of a number of research analyst reports. Zacks Investment Research upgraded shares of Summer Infant from a “strong sell” rating to a “hold” rating in a research note on Wednesday, April 25th. ValuEngine cut shares of Summer Infant from a “buy” rating to a “hold” rating in a research note on Tuesday, February 27th. Finally, Roth Capital reiterated a “buy” rating on shares of Summer Infant in a research note on Thursday, February 22nd. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Summer Infant presently has an average rating of “Buy” and a consensus price target of $2.50.

  • [By Joseph Griffin]

    Summer Infant (NASDAQ:SUMR) was downgraded by equities researchers at ValuEngine from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Friday.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Summer Infant (SUMR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com